Andreas Pircher
Impact in
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- Lung Cancer Research Studies
- Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Lung Cancer Treatments and Mutations 14
- Prostate Cancer Treatment and Research 13
- Lung Cancer Diagnosis and Treatment 9
- Oncology 31
- Cancer Immunotherapy and Biomarkers 18
- Lung Cancer Research Studies 6
- Co-authors
- Dominik Georg Friedrich Wolf (33 shared papers)Peter Carmeliet (7 shared papers)Bernard Thienpont (2 shared papers)Isabel Maria Heidegger (32 shared papers)Lena Horvath (9 shared papers)Wolfgang Hilbe (25 shared papers)Sara Aibar (1 shared paper)Birgit Weynand (1 shared paper)
- Journals
- Lung Cancer (9 papers)Cancer Cell (5 papers)Translational Lung Cancer Research (4 papers)Molecular Cancer (4 papers)International Journal of Molecular Sciences (3 papers)
- Partner nations
- AustriaGermanySwitzerland
In The Last Decade
Andreas Pircher
123 papers receiving 6.3k citations
Andreas Pircher's Hit Papers
Peers
Comparison fields: 5 of 109
- Oncology 1.7k
- Cancer Research 694
- Molecular Biology 2.4k
- Immunology 625
- Pulmonary and Respiratory Medicine 952
Countries citing papers authored by Andreas Pircher
This map shows the geographic impact of Andreas Pircher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Pircher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Pircher more than expected).
Fields of papers citing papers by Andreas Pircher
This network shows the impact of papers produced by Andreas Pircher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Pircher. The network helps show where Andreas Pircher may publish in the future.
Co-authors
The 25 scholars most cited alongside Andreas Pircher, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 131 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Phenotype molding of stromal cells in the lung tumor microenvironment Hit paper breakdown → | 2018 | 1236 |
| 2 | Inhibition of the Glycolytic Activator PFKFB3 in Endothelium Induces Tumor Vessel Normalization, Impairs Metastasis, and Improves Chemotherapy Hit paper breakdown → | 2016 | 544 |
| 3 | An Integrated Gene Expression Landscape Profiling Approach to Identify Lung Tumor Endothelial Cell Heterogeneity and Angiogenic Candidates Hit paper breakdown → | 2020 | 381 |
| 4 | High-Resolution Single-Cell Atlas Reveals Diversity and Plasticity of Tissue-Resident Neutrophils in Non-Small Cell Lung Cancer Hit paper breakdown → | 2022 | 330 |
| 5 | 2015 | 242 | |
| 6 | 2020 | 230 | |
| 7 | 2020 | 217 | |
| 8 | 2018 | 156 | |
| 9 | 2020 | 144 | |
| 10 | 2014 | 135 | |
| 11 | 2015 | 130 | |
| 12 | 2022 | 124 | |
| 13 | 2019 | 108 | |
| 14 | 2016 | 101 | |
| 15 | 2016 | 98 | |
| 16 | 2020 | 93 | |
| 17 | Sacituzumab Govitecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III EVOKE-01 Study Hit paper breakdown → | 2024 | 92 |
| 18 | 2017 | 80 | |
| 19 | 2011 | 76 | |
| 20 | 2016 | 74 |
About Andreas Pircher
Andreas Pircher is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Genetics and Hematology, having authored 131 papers that have together received 6.4k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (25 papers), Cancer Immunotherapy and Biomarkers (18 papers), Lung Cancer Treatments and Mutations (14 papers), Prostate Cancer Treatment and Research (13 papers), Lung Cancer Diagnosis and Treatment (9 papers), Single-cell and spatial transcriptomics (8 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Lung Cancer Research Studies (6 papers). The work is most often cited by research in Oncology (1.7k citations), Cancer Research (694 citations), Molecular Biology (2.4k citations), Immunology (625 citations) and Pulmonary and Respiratory Medicine (952 citations). Andreas Pircher has collaborated with scholars based in Austria, Germany and Switzerland. Frequent co-authors include Dominik Georg Friedrich Wolf, Peter Carmeliet, Bernard Thienpont, Isabel Maria Heidegger, Lena Horvath, Wolfgang Hilbe, Sara Aibar, Birgit Weynand, Johan Vansteenkiste and Herbert Decaluwé. Their work appears in journals such as Lung Cancer, Cancer Cell, Translational Lung Cancer Research, Molecular Cancer and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.